Bath & Body Works(US:BBWI) TMX Newsfile·2026-01-17 12:07Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - Following the release of Q3 2025 financial results on November 20, 2025, the company announced further cuts to its full-year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Context - Investors have until March 16, 2026, to request to be appointed to lead the class action case, which is pending in the U.S. District Court for the Southern District of Ohio, under the caption Lingam v. Bath & Body Works, Inc., et al. [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Bath & Body Works securities [3].